INNOVATIVE KEYS TO
HEALTH AND WELLBEING
Innokeys | News | New Marketing Authorization Approval in The Philippines for new indication of locally advanced unresectable or metastatic pancreatic cancer.
New Marketing Authorization Approval in The Philippines for new indication of locally advanced unresectable or metastatic pancreatic cancer.
Innokeys | September 18th, 2020

On 18 Sep 2020, Philippines FDA approved new marketing authorization for indication locally advanced unresectable or metastatic pancreatic cancer for nimotuzumab. This indication is added to previous indications: gliomas in adults and children, locally advanced SCCHN.

Innokeys Pte Ltd is a Singapore based limited liability company that was set up to leverage the value of innovation in the field of healthcare, especially in biopharmaceuticals.



© Copyrights Reserved INNOKEYS 2021
CONTACTS

200 Jalan Sultan #08-02
Textile Centre
Singapore 199018

INNOVATIVE KEYS
TO HEALTH AND WELLBEING